Related references
Note: Only part of the references are listed.Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia
Arnon Nagler et al.
HAEMATOLOGICA (2021)
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
Christina Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Arnon Nagler et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT
Jaime Sanz et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Impact of Total Body Irradiation-Based Myeloablative Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis
Farhad Khimani et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia
Bhagirathbhai Dholaria et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT
Noga Shem-Tov et al.
LEUKEMIA (2020)
Fludarabine and Total-Body Irradiation Conditioning before Ablative Haploidentical Transplantation: Long-Term Safety and Efficacy
Scott R. Solomon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Sebastian Giebel et al.
ANNALS OF HEMATOLOGY (2019)
The Role of Measurable Residual Disease (MRD) in Hematopoietic Stem Cell Transplantation for Hematological Malignancies Focusing on Acute Leukemia
Anna Czyz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT
Jiri Pavlu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Sebastian Giebel et al.
BONE MARROW TRANSPLANTATION (2019)
Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph-negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation
Anna Czyz et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study
Ioanna Sakellari et al.
ANNALS OF HEMATOLOGY (2018)
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia
Partbw Kebriaei et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Mar row Transplantation
Sebastian Giebel et al.
HAEMATOLOGICA (2017)
Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Mar row Transplantation
Sebastian Giebel et al.
HAEMATOLOGICA (2017)
Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Sandra Eder et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report
J. R. Passweg et al.
BONE MARROW TRANSPLANTATION (2017)
Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT
Jiri Pavlu et al.
CANCER (2017)
Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT
X. Cahu et al.
BONE MARROW TRANSPLANTATION (2016)
Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia
Kenjiro Mitsuhashi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Extreme Heterogeneity of Myeloablative Total Body Irradiation Techniques in Clinical Practice
Sebastian Giebel et al.
CANCER (2014)
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry
Loren Gragert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
Leo Luznik et al.
SEMINARS IN ONCOLOGY (2012)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Nonmalignant late effects after allogeneic stem cell transplantation
G Socié et al.
BLOOD (2003)
Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation
A Buchali et al.
RADIOTHERAPY AND ONCOLOGY (2000)
Share Paper
